Since the end of August, the administration of a vaccination booster, sometimes incorrectly called "third dose", has been recommended in France for people over 65 years of age and to certain people whose state of health makes them more vulnerable to severe forms. of Covid-19.
To discover
Covid-19: what we know about the Delta variant
Covid-19: the third vaccine dose, instructions for use
The campaign officially began in mid-September, with the suggestion to combine the injection of a dose of Pfizer-BionTech or Moderna with the flu shot.
Read also
Covid-19: should we fear the arrival of winter?
Countries that have launched their vaccination campaign early have a fairly close schedule and targets: Israel authorized the boosts at the end of July, Germany and Great Britain are due to start in September, followed by the United States.
These strategies were designed by observing the loss of vaccine efficacy “in real life”.
More than nine months after the first vaccinations in Israel, the United States or the United Kingdom, the results coming back from the field confirm that the protection decreases over time, especially in the elderly and those suffering from pain.
This article is for subscribers only.
You have 75% left to discover.
Pushing back the limits of science is also freedom.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
